1. Home
  2. TPHS vs BCDA Comparison

TPHS vs BCDA Comparison

Compare TPHS & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPHS
  • BCDA
  • Stock Information
  • Founded
  • TPHS 1959
  • BCDA N/A
  • Country
  • TPHS United States
  • BCDA United States
  • Employees
  • TPHS N/A
  • BCDA N/A
  • Industry
  • TPHS Building operators
  • BCDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TPHS Real Estate
  • BCDA Health Care
  • Exchange
  • TPHS Nasdaq
  • BCDA Nasdaq
  • Market Cap
  • TPHS 7.8M
  • BCDA 9.4M
  • IPO Year
  • TPHS N/A
  • BCDA N/A
  • Fundamental
  • Price
  • TPHS $0.12
  • BCDA $2.95
  • Analyst Decision
  • TPHS
  • BCDA Strong Buy
  • Analyst Count
  • TPHS 0
  • BCDA 1
  • Target Price
  • TPHS N/A
  • BCDA $60.00
  • AVG Volume (30 Days)
  • TPHS 8.4M
  • BCDA 86.1K
  • Earning Date
  • TPHS 03-30-2023
  • BCDA 08-07-2024
  • Dividend Yield
  • TPHS N/A
  • BCDA N/A
  • EPS Growth
  • TPHS N/A
  • BCDA N/A
  • EPS
  • TPHS N/A
  • BCDA N/A
  • Revenue
  • TPHS $21,231,000.00
  • BCDA $468,000.00
  • Revenue This Year
  • TPHS N/A
  • BCDA N/A
  • Revenue Next Year
  • TPHS N/A
  • BCDA $436.41
  • P/E Ratio
  • TPHS N/A
  • BCDA N/A
  • Revenue Growth
  • TPHS N/A
  • BCDA N/A
  • 52 Week Low
  • TPHS $0.08
  • BCDA $2.62
  • 52 Week High
  • TPHS $0.57
  • BCDA $35.40
  • Technical
  • Relative Strength Index (RSI)
  • TPHS 46.91
  • BCDA 37.81
  • Support Level
  • TPHS $0.12
  • BCDA $2.84
  • Resistance Level
  • TPHS $0.13
  • BCDA $3.66
  • Average True Range (ATR)
  • TPHS 0.01
  • BCDA 0.32
  • MACD
  • TPHS 0.00
  • BCDA 0.09
  • Stochastic Oscillator
  • TPHS 45.50
  • BCDA 17.44

About TPHS Trinity Place Holdings Inc.

Trinity Place Holdings Inc is a real estate holding, investment, and asset management company. It is primarily engaged in owning, investing in, managing, developing or redeveloping real estate assets and real estate-related securities. It also controls a range of intellectual property assets focused on the consumer sector, including its online marketplace at FilenesBasement.com, its rights to the Stanley Blacker brand, and the intellectual property associated with the Running of the Brides event. The company generates revenue from Rental revenue, Other Income, and Sales of residential condominium units.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: